Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 150,049 | 316,889 | 458,480 | 283,255 | 118,095 |
| Depreciation Amortization | 35,948 | 92,261 | 63,727 | 41,806 | 20,586 |
| Income taxes - deferred | 3,428 | 634 | 17,402 | -9,952 | -2,858 |
| Accounts receivable | -19,547 | -128,063 | -37,580 | -7,884 | 3,834 |
| Other Working Capital | -26,198 | -152,256 | -142,827 | -84,547 | 7,472 |
| Other Operating Activity | 36,398 | 522,093 | 73,327 | 31,254 | 7,092 |
| Operating Cash Flow | $180,078 | $651,558 | $432,529 | $253,932 | $154,221 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 154 | 474,893 | -247,355 | -3,121 | -89,472 |
| PPE Investments | -3,741 | -6,970 | 443,330 | -2,513 | -950 |
| Net Acquisitions | 710 | -1,013,736 | N/A | N/A | N/A |
| Investing Cash Flow | $-2,877 | $-545,813 | $195,975 | $-5,634 | $-90,422 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,470,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -1,229,693 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 21,829 | 17,683 | -302,287 | N/A |
| Common Stock Repurchased | N/A | -342,372 | -342,372 | N/A | N/A |
| Other Financing Activity | -1,613 | -4,938 | 0 | 0 | -3,321 |
| Financing Cash Flow | $-1,613 | $-85,174 | $-324,689 | $-302,287 | $-3,321 |
| Beginning Cash Position | 136,421 | 115,850 | 115,850 | 115,850 | 115,850 |
| End Cash Position | 312,009 | 136,421 | 419,665 | 61,861 | 176,328 |
| Net Cash Flow | $175,588 | $20,571 | $303,815 | $-53,989 | $60,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | 180,078 | 651,558 | 432,529 | 253,932 | 154,221 |
| Capital Expenditure | -3,741 | -6,970 | -5,543 | -2,513 | -950 |
| Free Cash Flow | 176,337 | 644,588 | 426,986 | 251,419 | 153,271 |